tiprankstipranks
Advertisement
Advertisement
Craig-Hallum bullish on Compass Therapeutics, initiates with a Buy
PremiumThe FlyCraig-Hallum bullish on Compass Therapeutics, initiates with a Buy
1M ago
Compass Therapeutics initiated with a Buy at Craig-Hallum
Premium
The Fly
Compass Therapeutics initiated with a Buy at Craig-Hallum
1M ago
Compass Therapeutics price target raised to $13 from $10 at Canaccord
Premium
The Fly
Compass Therapeutics price target raised to $13 from $10 at Canaccord
2M ago
Compass Therapeutics appoints Arjun Prasad as CCO, Cynthia Sirard as CMO
PremiumThe FlyCompass Therapeutics appoints Arjun Prasad as CCO, Cynthia Sirard as CMO
3M ago
Compass Therapeutics initiated with an Outperform at William Blair
Premium
The Fly
Compass Therapeutics initiated with an Outperform at William Blair
3M ago
Compass Therapeutics: Emerging Bispecific Portfolio Positions Tovecimig to Redefine Second-Line Biliary Tract Cancer Standard of Care
Premium
Ratings
Compass Therapeutics: Emerging Bispecific Portfolio Positions Tovecimig to Redefine Second-Line Biliary Tract Cancer Standard of Care
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100